Shares of GenMark Diagnostics Inc. (GNMK) are currently trading up 30% on Tuesday morning trade. The molecular diagnostics solutions provider reported fourth-quarter loss that narrowed from last year, while revenues surged 40%.
from RTT - Earnings https://ift.tt/3cxtUGz
via IFTTT
No comments:
Post a Comment